New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress

Surachet Imlimthan, Euy Sung Moon, Hendrik Rathke, Ali Afshar-Oromieh, Frank Rösch, Axel […]

2022-06-30T15:08:38+00:00October 5th, 2021|Publications|

SOFIE promotes Scott Boller to Chief Financial Officer

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has promoted the company’s […]

2021-09-24T16:17:54+00:00September 24th, 2021|News|

Dr. Michael E. Phelps Awarded the Pioneer in Medicine Award from the Society of Brain Mapping & Therapeutics

The Society for Brain Mapping and Therapeutics (SBMT), the leading multi-specialty association for Brain Mapping, is […]

2021-07-09T15:57:19+00:00July 9th, 2021|News|

SOFIE to Commercially Supply FDA-Approved PYLARIFY® (piflufolastat F 18) Injection

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially […]

2021-05-28T12:41:23+00:00May 28th, 2021|News|

Brian Schumer joins SOFIE as Chief Operating Officer

We are excited to welcome Brian Schumer to the SOFIE team. Brian joins SOFIE […]

2021-05-17T18:47:58+00:00May 6th, 2021|News|

SOFIE executes order to purchase a top-of-the line GE PETtrace 890

SOFIE has placed a purchase order for GE […]

2021-05-19T01:02:01+00:00April 15th, 2021|News|

SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast Activation Protein (FAP) targeted theranostics

  • Novartis has acquired global development and commercial rights to therapeutic applications for iTheranostics’ library […]
2021-05-19T01:02:30+00:00March 30th, 2021|News|

SOFIE Inc. enters into partnership with AUGMENTICON™

AUGMENTICON™, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools for a cost-effective, high-quality manufacturing […]

2021-05-19T01:09:10+00:00March 16th, 2021|News|

FAPI-74 PET/CT Using Either 18 F-AlF or Cold-Kit 68 Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients

Frederik L Giesel 1, Sebastian Adeberg

2021-04-26T00:57:10+00:00February 24th, 2021|Publications|

68 Ga-NOTA-FAPI-04 PET/CT in a patient with primary gastric diffuse large B cell lymphoma: comparisons with [ 18 F] FDG PET/CT

Guochang Wang # 1, Xiao Jin 

2021-04-26T01:20:52+00:00February 24th, 2021|Publications|
© Copyright |   Privacy Policy   |   All Rights Reserved   |   Powered by jscTEK   1.703.787.7900           Email Us
Go to Top